Jacobs Levy Equity Management, Inc Codexis, Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $24.7 Billion
- Q3 2024
A detailed history of Jacobs Levy Equity Management, Inc transactions in Codexis, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 895,695 shares of CDXS stock, worth $3.35 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
895,695
Previous 1,009,889
11.31%
Holding current value
$3.35 Million
Previous $3.13 Million
11.88%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding CDXS
# of Institutions
125Shares Held
59.9MCall Options Held
25.9KPut Options Held
20.1K-
Opaleye Management Inc. Boston, MA8.77MShares$32.8 Million4.93% of portfolio
-
Casdin Capital, LLC New York, NY8.1MShares$30.3 Million1.94% of portfolio
-
Black Rock Inc. New York, NY6.79MShares$25.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.15MShares$15.5 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.97MShares$11.1 Million0.54% of portfolio
About CODEXIS, INC.
- Ticker CDXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,494,100
- Market Cap $245M
- Description
- Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...